Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis - PubMed
3 months ago
- #Cirrhosis
- #MRI
- #Hepatocellular Carcinoma
- Gadoxetate-enhanced MRI showed higher quality scores (80.4% MR-A) compared to US (24.2% US-A) in HCC screening for cirrhosis patients.
- Obesity negatively impacted image quality in both MRI and US, though only significant in univariable analysis.
- Child-Pugh B/C scores significantly reduced MRI quality in both univariable and multivariable analyses.
- The study suggests MRI as a more reliable imaging modality for HCC screening in cirrhosis patients, especially where US quality is limited.